Genes and chronic obstructive pulmonary disease

Marilyn G. Foreman, Michael A Campos, Juan C. Celedón

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The marked variability in individual susceptibility to the detrimental effects of smoking on lung function and other findings suggest a significant genetic contribution to chronic obstructive pulmonary disease (COPD). The only known genetic risk factor for COPD, severe a 1-antitrypsin (AAT) deficiency, explains only 1% to 2% of cases of this disease. Screening for severe AAT should be done in all cases of COPD. There is considerable interest in identifying susceptibility genes for COPD unrelated to severe AAT deficiency, as this could greatly enhance efforts to prevent, diagnose, and treat COPD by yielding novel insights into its pathogenesis.

Original languageEnglish
Pages (from-to)699-711
Number of pages13
JournalMedical Clinics of North America
Volume96
Issue number4
DOIs
StatePublished - Jul 1 2012

Fingerprint

Chronic Obstructive Pulmonary Disease
Genes
Smoking
Lung

Keywords

  • α -antitrypsin deficiency
  • COPD
  • Genetics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Genes and chronic obstructive pulmonary disease. / Foreman, Marilyn G.; Campos, Michael A; Celedón, Juan C.

In: Medical Clinics of North America, Vol. 96, No. 4, 01.07.2012, p. 699-711.

Research output: Contribution to journalArticle

Foreman, Marilyn G. ; Campos, Michael A ; Celedón, Juan C. / Genes and chronic obstructive pulmonary disease. In: Medical Clinics of North America. 2012 ; Vol. 96, No. 4. pp. 699-711.
@article{d5324f09ccda41b18774c2139cb77ca5,
title = "Genes and chronic obstructive pulmonary disease",
abstract = "The marked variability in individual susceptibility to the detrimental effects of smoking on lung function and other findings suggest a significant genetic contribution to chronic obstructive pulmonary disease (COPD). The only known genetic risk factor for COPD, severe a 1-antitrypsin (AAT) deficiency, explains only 1{\%} to 2{\%} of cases of this disease. Screening for severe AAT should be done in all cases of COPD. There is considerable interest in identifying susceptibility genes for COPD unrelated to severe AAT deficiency, as this could greatly enhance efforts to prevent, diagnose, and treat COPD by yielding novel insights into its pathogenesis.",
keywords = "α -antitrypsin deficiency, COPD, Genetics",
author = "Foreman, {Marilyn G.} and Campos, {Michael A} and Celed{\'o}n, {Juan C.}",
year = "2012",
month = "7",
day = "1",
doi = "10.1016/j.mcna.2012.02.006",
language = "English",
volume = "96",
pages = "699--711",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Genes and chronic obstructive pulmonary disease

AU - Foreman, Marilyn G.

AU - Campos, Michael A

AU - Celedón, Juan C.

PY - 2012/7/1

Y1 - 2012/7/1

N2 - The marked variability in individual susceptibility to the detrimental effects of smoking on lung function and other findings suggest a significant genetic contribution to chronic obstructive pulmonary disease (COPD). The only known genetic risk factor for COPD, severe a 1-antitrypsin (AAT) deficiency, explains only 1% to 2% of cases of this disease. Screening for severe AAT should be done in all cases of COPD. There is considerable interest in identifying susceptibility genes for COPD unrelated to severe AAT deficiency, as this could greatly enhance efforts to prevent, diagnose, and treat COPD by yielding novel insights into its pathogenesis.

AB - The marked variability in individual susceptibility to the detrimental effects of smoking on lung function and other findings suggest a significant genetic contribution to chronic obstructive pulmonary disease (COPD). The only known genetic risk factor for COPD, severe a 1-antitrypsin (AAT) deficiency, explains only 1% to 2% of cases of this disease. Screening for severe AAT should be done in all cases of COPD. There is considerable interest in identifying susceptibility genes for COPD unrelated to severe AAT deficiency, as this could greatly enhance efforts to prevent, diagnose, and treat COPD by yielding novel insights into its pathogenesis.

KW - α -antitrypsin deficiency

KW - COPD

KW - Genetics

UR - http://www.scopus.com/inward/record.url?scp=84863819831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863819831&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2012.02.006

DO - 10.1016/j.mcna.2012.02.006

M3 - Article

C2 - 22793939

AN - SCOPUS:84863819831

VL - 96

SP - 699

EP - 711

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 4

ER -